Recludix pharma is a developing platform to treat cancer patients.
Recludix Pharma's investors include Eli Lilly, New Enterprise Associates, Westlake Village BioPartners, Alexandria Venture Investments, Access Biotechnology.
Recludix Pharma is headquartered in San Diego, United States.
Recludix pharma is a developing platform to treat cancer patients.
Recludix Pharma is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Recludix Pharma — Funding & Investors." VCBacked, January 12, 2026, https://www.vcbacked.co/company/recludix-pharma. Accessed September 13, 2026.
VCBacked. (2026). Recludix Pharma — Funding & Investors. Retrieved September 13, 2026, from https://www.vcbacked.co/company/recludix-pharma
{{cite web |title=Recludix Pharma — Funding & Investors |url=https://www.vcbacked.co/company/recludix-pharma |website=VCBacked |access-date=September 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated